A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of Patients

NCT05198817 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumors

Interventions

DRUG: SHR-2002 injection、Camrelizumab for Injection, SHR-1316 injection, SHR-1701 injection

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.